» Articles » PMID: 14623912

Memory CD8+ T Cells Provide Innate Immune Protection Against Listeria Monocytogenes in the Absence of Cognate Antigen

Overview
Journal J Exp Med
Date 2003 Nov 19
PMID 14623912
Citations 194
Authors
Affiliations
Soon will be listed here.
Abstract

Interferon (IFN)-gamma plays an important role in the innate immune response against intracellular bacterial pathogens. It is commonly thought that natural killer cells are the primary source of this cytokine that is involved in activating antibacterial effects in infected cells and polarizing CD4+ T cells toward the Th1 subset. However, here we show that both effector and memory CD8+ T cells have the potential to secrete IFN-gamma in response to interleukin (IL)-12 and IL-18 in the absence of cognate antigen. We demonstrate that memory CD8+ T cells specific for the ovalbumin protein secrete IFN-gamma rapidly after infection with wild-type Listeria monocytogenes (LM). Furthermore, small numbers of ovalbumin-specific, memory CD8+ T cells can reduce spleen and liver bacterial counts in IFN-gamma-deficient mice 3 d after LM infection. Up-regulation of the receptors for IL-12 and IL-18 provides a mechanism for the ability of memory CD8+ T cells to respond in this antigen nonspecific manner. Thus, CD8+ T cells play an important role in the innate immune response against intracellular pathogens by rapidly secreting IFN-gamma in response to IL-12 and IL-18.

Citing Articles

Memory Cells in Infection and Autoimmunity: Mechanisms, Functions, and Therapeutic Implications.

Giri S, Batra L Vaccines (Basel). 2025; 13(2).

PMID: 40006751 PMC: 11860616. DOI: 10.3390/vaccines13020205.


Terminal differentiation and persistence of effector regulatory T cells essential for preventing intestinal inflammation.

Dikiy S, Ghelani A, Levine A, Martis S, Giovanelli P, Wang Z Nat Immunol. 2025; 26(3):444-458.

PMID: 39905200 PMC: 11876075. DOI: 10.1038/s41590-024-02075-6.


Mechanisms governing bystander activation of T cells.

Yosri M, Dokhan M, Aboagye E, Moussawy M, Abdelsamed H Front Immunol. 2024; 15:1465889.

PMID: 39669576 PMC: 11635090. DOI: 10.3389/fimmu.2024.1465889.


The CML experience to elucidate the role of innate T-cells as effectors in the control of residual cancer cells and as potential targets for cancer therapy.

Decroos A, Meddour S, Demoy M, Piccirilli N, Rousselot P, Nicolini F Front Immunol. 2024; 15:1473139.

PMID: 39620210 PMC: 11604645. DOI: 10.3389/fimmu.2024.1473139.


DAMP-ing IBD: Extinguish the Fire and Prevent Smoldering.

Sandys O, Stokkers P, Te Velde A Dig Dis Sci. 2024; 70(1):49-73.

PMID: 38963463 PMC: 11761125. DOI: 10.1007/s10620-024-08523-5.


References
1.
Hameg A, Arnould A, Machavoine F, Koezuka Y, Schneider E, Herbelin A . A distinct IL-18-induced pathway to fully activate NK T lymphocytes independently from TCR engagement. J Immunol. 1999; 163(11):5871-6. View

2.
Bancroft G . The role of natural killer cells in innate resistance to infection. Curr Opin Immunol. 1993; 5(4):503-10. DOI: 10.1016/0952-7915(93)90030-v. View

3.
den Haan J, Lehar S, Bevan M . CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J Exp Med. 2000; 192(12):1685-96. PMC: 2213493. DOI: 10.1084/jem.192.12.1685. View

4.
Lertmemongkolchai G, Cai G, Hunter C, Bancroft G . Bystander activation of CD8+ T cells contributes to the rapid production of IFN-gamma in response to bacterial pathogens. J Immunol. 2001; 166(2):1097-105. DOI: 10.4049/jimmunol.166.2.1097. View

5.
Heath W, Carbone F . Cross-presentation, dendritic cells, tolerance and immunity. Annu Rev Immunol. 2001; 19:47-64. DOI: 10.1146/annurev.immunol.19.1.47. View